Optionele productanalyse
Met uw toestemming gebruiken we privacyvriendelijke, beperkte analyses om te begrijpen welke onderzoeksroutes werken. We gebruiken geen advertentietrackers of sessieopnamen. U kunt deze keuze wijzigen in Voorkeuren. Lees het Privacybeleid.
Welltower Inc.'s published Sell conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $164.9B | |
|---|---|---|
| Revenue (ttm) | 13.8B | |
| Net income (ttm) | 1.7B | |
| EPS (ttm) | $2.32 | |
| Shares out | 733.6M | |
| P/E (trailing) | 97.8x | |
| P/E (forward) | 77.5x | |
| Dividend | $3.40 (1.50%) | |
| Volume | 4,867,974 | |
| Beta | 0.75 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $3.20B | $4.17B | $4.75B | $6.03B | $8.45B | +27.5% |
| Gross profit | $1.93B | $2.22B | $2.53B | $3.02B | $4.18B | +21.2% |
| Operating income | $660.6M | $702.6M | $957.9M | $1.10B | $171.9M | -28.6% |
| Net income | $336.1M | $141.2M | $340.1M | $951.7M | $936.8M | +29.2% |
| EPS (diluted) | $0.78 | $0.30 | $0.66 | $1.57 | $1.39 | +15.5% |
| EBITDA | $1.71B | $2.04B | $2.40B | $2.78B | $2.31B | +7.8% |
| R&D | $0 | $0 | $0 | — | — | +11.8% |
| SG&A | $126.7M | $150.4M | $179.1M | $235.5M | $1.75B | +92.7% |
Recent company headlines from major financial publishers.
The base path projects steady occupancy recovery across senior housing facilities, with annual resident rate increases offsetting labor expenses. Contractual rental income from triple-net and outpatient properties provides cash flow stability, leading to an intrinsic target of $73.89 representing an expected return of -68.3% with probability 60.0%.
The bull path envisions accelerating senior housing occupancy exceeding pre-pandemic peaks, coupled with double-digit RevPOR growth that drives operating margins above historical norms. Capital deployment via accretive acquisitions further enhances cash generation, yielding an intrinsic target of $82.97 and an expected return of -64.4% with probability 20.0%.
| Ke ↓ / g → | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% |
|---|---|---|---|---|---|
| 6.1% | $111 | $113 | $116 | $120 | $125 |
| 7.1% | $87.4 | $88.9 | $90.6 | $92.8 | $95.6 |
| 8.1% | $71.8 | $72.7 | $73.9 | $75.3 | $77.0 |
| 9.1% | $61.3 | $62.0 | $62.8 | $63.7 | $64.9 |
| 10.1% | $53.3 | $53.8 | $54.4 | $55.1 | $55.9 |
Upcoming earnings date and setup when available.
De rating die de gepubliceerde researcheditie van elke maand droeg. Een rating vergelijkt de koers op de analysedatum met de fair value; het is geen overzicht van of de inschatting juist bleek.
| Jaar | jan | feb | mrt | apr | mei | jun | jul | aug | sep | okt | nov | dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
